Air Liquide Enters a Long-term Partnership to Secure Its Supply of Helium-3
Air Liquide has entered a long-term agreement with Laurentis Energy Partners to produce and distribute helium-3 (3He), a rare isotope used across various high-tech applications including quantum computing and medical imaging. The helium-3 will be extracted from the Darlington power station in Canada and Air Liquide will handle purification and global distribution. Production is set to commence by the end of this year. This partnership strengthens Air Liquide's position in the clean-energy and quantum technology markets, enhancing its service offerings and supporting sustainable growth.
- Long-term agreement with Laurentis Energy Partners enhances Air Liquide's capabilities in helium-3 production.
- Expands Air Liquide's entry into the growing quantum technology market.
- Production commencement by year-end 2023 ensures timely market supply.
- None.
Air Liquide (Paris:AI) has entered into a long-term agreement with
Helium-3 is a very rare and stable isotope of helium. Compared to the most common isotope (helium-4), helium-3 has unique physical properties, such as a lower liquefaction temperature. Thanks to this, helium-3 has a wide range of applications, from neutron detection for security gates to deep science where helium-3 allows to reach temperatures close to absolute zero. In particular, helium-3 is necessary to produce the ultra cold required by quantum computers that harness quantum physics to process exponentially more data compared to classical computers. The promise of quantum computing is accelerated development in many fields including the search for new drugs, the discovery of new materials, and even cyber defense. As a medical isotope, He-3 can also be used to produce highly detailed Magnetic Resonance Imaging (MRI) of airways in the lung.
Global Markets & Technologies
The
A world leader in gases, technologies and services for Industry and Health, Air Liquide is present in 78 countries with approximately 64,500 employees and serves more than 3.8 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the company’s activities since its creation in 1902.
Air Liquide’s ambition is to be a leader in its industry, deliver long term performance and contribute to sustainability - with a strong commitment to climate change and energy transition at the heart of its strategy. The company’s customer-centric transformation strategy aims at profitable, regular and responsible growth over the long term. It relies on operational excellence, selective investments, open innovation and a network organization implemented by the Group worldwide. Through the commitment and inventiveness of its people, Air Liquide leverages energy and environment transition, changes in healthcare and digitization, and delivers greater value to all its stakeholders.
Air Liquide’s revenue amounted to more than
www.airliquide.com
Follow us on Twitter @airliquidegroup
View source version on businesswire.com: https://www.businesswire.com/news/home/20211207005777/en/
Corporate Communications
media@airliquide.com
Investor Relations
IRTeam@airliquide.com
Source: Air Liquide
FAQ
What is the significance of Air Liquide's agreement with Laurentis Energy Partners regarding helium-3?
When does Air Liquide plan to start helium-3 production?
How does helium-3 benefit quantum computing?
What are the applications of helium-3 besides quantum computing?